Kymera Therapeutics, Inc. (KYMR)
108.69
+3.91
(+3.73%)
USD |
NASDAQ |
Oct 19, 13:00
Kymera Therapeutics EPS Diluted (Quarterly) : -0.6235 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6235 |
| March 31, 2026 | -0.7098 |
| December 31, 2025 | -0.9674 |
| September 30, 2025 | -0.9413 |
| June 30, 2025 | -0.9523 |
| March 31, 2025 | -0.8183 |
| December 31, 2024 | -0.8845 |
| September 30, 2024 | -0.8208 |
| June 30, 2024 | -0.5757 |
| March 31, 2024 | -0.6861 |
| December 31, 2023 | -0.2455 |
| September 30, 2023 | -0.9049 |
| June 30, 2023 | -0.6652 |
| March 31, 2023 | -0.7034 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.6023 |
| September 30, 2022 | -0.7885 |
| June 30, 2022 | -0.7776 |
| March 31, 2022 | -0.7102 |
| December 31, 2021 | -0.6596 |
| September 30, 2021 | -0.5636 |
| June 30, 2021 | -0.5468 |
| March 31, 2021 | -0.2928 |
| December 31, 2020 | -0.2853 |
| September 30, 2020 | -0.3862 |
| June 30, 2020 | -0.3243 |
| March 31, 2020 | -0.4487 |
| December 31, 2019 | -0.2584 |
| September 30, 2019 | -0.2565 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.7989 |
| Twist Bioscience Corp. | -0.5617 |
| Beam Therapeutics, Inc. | -1.176 |
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -61.21M |
| Revenue (Quarterly) | 65.00M |
| Total Expenses (Quarterly) | 126.21M |
| Enterprise Value | 8.062B |
| Gross Profit Margin (Quarterly) | 96.88% |
| Profit Margin (Quarterly) | -94.17% |
| Earnings Yield | -2.98% |
| Normalized Earnings Yield | -2.954 |